Keiji AI Fact Sheet
Keiji AI fact sheet
The company, the platform, and the research on one page, for analysts, partners, press, and procurement teams.
Last updated October 2026
Keiji AI Fact Sheet
keiji.ai · Last updated October 2026
Company overview
- Company
- Keiji AI, Inc.
- Founded
- 2023
- Headquarters
- United States
- Product
- TrialMind, a platform of AI agents for clinical research
- Category
- Business software, delivered as a hosted service (SaaS), for pharma, biotech, contract research organizations (CROs), and academic medical centers
- Deployment
- Cloud, private cloud, or your own environment, with access through an application programming interface (API) and the Model Context Protocol (MCP)
- Website
- keiji.ai
Keiji AI builds TrialMind, AI agents for clinical research teams — biostatistics and trial design, real-world evidence, HEOR, competitive intelligence, and clinical operations. Every output carries citations, traceable logic, and an audit trail, so a regulated team can defend it.
What TrialMind does
Biostatistics & Trial Design
Statistical programming from the statistical analysis plan (SAP) to CDISC datasets and tables, listings, and figures (TLFs), plus trial design and simulation, with an audit trail on every output.
Real-World Evidence
Feasibility and cohort analyses on the real-world data you already license, in minutes rather than weeks.
Competitive & Portfolio Intelligence
Clinical trial landscapes, key opinion leader (KOL) discovery, and probability-of-success estimates, each linked to primary sources.
Clinical Development & Operations
Site selection, patient recruitment, enrollment and dropout prediction, and ongoing data monitoring.
Health Economics & Market Access
Systematic literature reviews, indirect treatment comparisons, and health technology assessment (HTA) dossiers, with methods a reviewer can audit.
Research Institutions
Licensed to departments and research groups, so investigators can run their own studies.
Data standards supported
Research background
Keiji AI came out of an AI research lab at the University of Illinois Urbana-Champaign.
The team publishes peer-reviewed work in Nature, Nature Biomedical Engineering, Nature Communications, Nature Machine Intelligence, npj Digital Medicine, and top AI venues including NeurIPS, ICLR, EMNLP, and KDD.
Security and compliance
- SOC 2 Type I & II
- Audited — Service Organization Control 2 (SOC 2): independent attestation of security, availability, and confidentiality controls
- ISO 27001
- Certified — international standard for an information security management system (ISMS)
- HIPAA
- Compliant — Health Insurance Portability and Accountability Act (HIPAA) safeguards for protected health information (PHI), with business associate agreements (BAAs) available
- GxP
- Qualified — GxP (good practice regulations such as good clinical practice): Data Science Assistant v1.0.0, qualified using the GAMP 5 (Good Automated Manufacturing Practice) risk-based approach, with controls for 21 CFR Part 11 (FDA rules for electronic records and signatures) and EU Annex 11 (European rules for computerized systems)
Controls
- Encryption of stored data (AES-256) and of data in transit (TLS 1.2 or later)
- Multi-factor authentication and role-based access control
- Network segmentation, regular security assessments, and vulnerability scanning
- Documented incident response procedures, with customer notification of security incidents
Customers
In production with pharmaceutical and biotech companies, contract research organizations, and academic medical centers.
Contact
- General & press
- contact@keiji.ai
- Security
- security@keiji.ai
- Support
- support@keiji.ai
Request a demo
Tell us what you work on, and we will walk through the agents that touch it.